Global Graves Disease Treatment Market­ Booming Worldwide to Show Significant Growth by 2026| Pfizer Inc, AbbVie Inc, Mylan N.V, Apitope, Merck KGaA, Amgen Inc, , Horizon Therapeutics plc, Medtronic

(CDN Newswire via Comtex)

Graves disease treatment market­ is expected to grow at a steady CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the rise in number of patients with thyroid disorders, favorable reimbursement policies for treatment and increase in awareness about the complications associated with thyroid disorders and rising investment in the research & development of treatments for Hashimoto's thyroiditis is expected to drive the market.

This market analysis gives an examination of various segments that are relied upon to witness the quickest development amid the estimate forecast frame. Global Graves disease treatment market research report puts light on the types of customers, product-buyer insights, and market changes over last few years, reactions of various geographic regions, new developments in the market, actions of other corporate players and more. All the statistics are signified in graphical and tabular format for a clear understanding on facts and figures. The report suggests that by accomplishing an inspiration from the marketing strategies of rivals, businesses can set up inventive ideas and striking sales targets which in turn make them achieve competitive advantage over its competitors.

Ask For Complimentary Sample PDF| Request At

Key Market Players:

The key market players in the global Graves disease treatment market­ are Abbott, GlaxoSmithKline plc, ALLERGAN, Novartis AG, Merck & Co., Inc, Sanofi, Pfizer Inc, AbbVie Inc, Mylan N.V, Apitope, Merck KGaA, Amgen Inc, , Horizon Therapeutics plc, Medtronic, Immunovant, Inc, among others

Market Drivers

High prevalence of autoimmune diseases such as Grave's disease and Hashimoto's thyroiditis is driving the market growth

Various national health programs related to thyroid disease that raise awareness regarding such diseases further boosts the growth of this market

Favorable reimbursement policies for the treatment

Increasing iodine disorder and thyroid tumors screening is also fueling the market growth

Market Restraints

High costs associated with the treatment and the usage of alternative medicines for the treatment of thyroid disorders is hindering the market growth

Side-effects associated with the current medication also restricts the market growth

Stringent government regulations is hampering the market growth

Key Developments in the Market

In June 2019, Horizon Therapeutics plc is developing teprotumumab, a complex protein that works by inhibiting the insulin-like growth factor I receptor (IGF-1R) for the treatment of Graves disease, currently ongoing in phase lll of OPTIC l trial. With this development the company provides better solution for the treatment of graves disease

In June 2019, Apitope is developing a novel drug ATX-GD-59, a peptide mixture of two different, highly soluble apitopes derived from TSH-receptor for the treatment of Graves disease currently ongoing in phase l clinical trial. If approved it will become the first innovative treatment in more than 60 years and will provide potential treatment to target the immunological basis of Graves' disease

View detailed table of content @

Segmentation: Global Graves Disease Treatment Market­

By Mechanism of Action Type

Anti-thyroid Agents

Beta Blockers



By Drugs






By Diagnosis

Physical Exam

Blood Test

Radioactive Iodine Uptake Test


Imaging Tests

By Treatment


Radioactive Iodine Therapy



By Route of Administration




By Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

By End-Users



Specialty Clinics


By Geography

North America



South America

Middle East & Africa

Inquiry For Customize Report With Discount at

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.


Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at [email protected].